Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years or Older: a Multicenter, Retrospective Cohort Study Based on Phase III Trial

NCT07585370 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.

NCT NCT07585370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years or Older: a Multicenter, Retrospective Cohort Study Based on Phase III Trial
Lead sponsor
Jiangsu Province Centers for Disease Control and Prevention
Phase
Observational
Overall status
Recruiting
Start date
March 6, 2026
Completion date
June 30, 2026
Enrollment
24,740 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster